Pharmaceutical development
Employ Genialis ResponderID™ to develop and deploy a biomarker for patient stratification
- Support your clinical development with the insights from a comprehensive RNA biomarker
- Improve the likelihood of achieving clinical endpoints and maximize clinical development program ROI
- Increase speed to successful trial conclusion (minimize late-stage failures) for faster commercialization Prioritize additional therapeutic opportunities based on potentially responsive patient populations
Utilize off-the-shelf Genialis biomarkers for retrospective analysis
- Learn more about hallmark biologies driving cancer development in your existing samples
- Add value to your translational and clinical decision making immediately, via streamlined contracting for immediate project initiation
- Receive insights in a hurry with quick analysis turnaround time
Diagnostic test development
Develop new prognostic or predictive tests atop existing sequencing workflows
- Expand product line to cover more therapeutic settings and reach more patients
- Differentiate test offerings from other providers using machine learning
Compound the value of your data assets through new product offerings and data mining capabilities
- Leverage new and existing data to attract more pharmaceutical business and energize novel business models
- Identify signatures that support translational research, clinical trials & companion diagnostic (CDx) development
Clinical & academic data partnership
Translate your data resources into meaningful patient outcomes
- Turn your biospecimen samples into sequencing data via a research program sponsored by Genialis, or via a joint grant application
- Develop your initial biomarker idea into a robust biomarker that will translate to patients and pass regulatory muster
- Impact patient lives through diagnostic and therapeutic biomarker discovery for existing therapies
Advance your organization’s mandate through flexible business models
- Attract biotech partners for sponsored research and licensing opportunities
- Publish high impact clinical research to disseminate knowledge and drive future grant funding
